| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0.001 | 0.98 | Cyclin A1 inhibitor | 0.789 0.001 DBMET02363 0.698 0.001 DBMET02366 0.789 0.001 DBMET02364 0.616 0.002 DBMET02365 0.512 0.002 DBMET02372 0.833 0.001 DBMET02371 0.963 0.001 DBMET02373 0.28 0.003 DBMET02374 0.646 0.002 DBMET02375 0.689 0.002 DBMET02376 0.544 0.002 DBMET02377 0.883 0.001 DBMET02378 0.885 0.001 DBMET02379 0.972 0.001 DBMET02380 | ||
| 0.972 | 0 | 0.972 | Cyclin D2 inhibitor | 0.756 0 DBMET02363 0.645 0 DBMET02366 0.756 0 DBMET02364 0.581 0 DBMET02365 0.238 0.001 DBMET02372 0.326 0 DBMET02371 0.843 0 DBMET02373 0.288 0.001 DBMET02374 0.574 0 DBMET02375 0.579 0 DBMET02376 0.263 0.001 DBMET02377 0.708 0 DBMET02378 0.741 0 DBMET02379 0.905 0 DBMET02380 | ||
| 0.917 | 0.002 | 0.917 | Cyclin-dependent kinase 4 inhibitor | 0.793 0.002 DBMET02363 0.762 0.002 DBMET02366 0.793 0.002 DBMET02364 0.878 0.002 DBMET02365 0.716 0.002 DBMET02372 0.755 0.002 DBMET02371 0.875 0.002 DBMET02373 0.821 0.002 DBMET02374 0.788 0.002 DBMET02375 0.806 0.002 DBMET02376 0.721 0.002 DBMET02377 0.812 0.002 DBMET02378 0.823 0.002 DBMET02379 0.852 0.002 DBMET02380 | ||
| 0.913 | 0.001 | 0.913 | Cyclin A2 inhibitor | 0.744 0.002 DBMET02363 0.649 0.002 DBMET02366 0.744 0.002 DBMET02364 0.867 0.002 DBMET02365 0.498 0.003 DBMET02372 0.629 0.003 DBMET02371 0.804 0.002 DBMET02373 0.615 0.003 DBMET02374 0.714 0.002 DBMET02375 0.587 0.003 DBMET02376 0.413 0.004 DBMET02377 0.751 0.002 DBMET02378 0.795 0.002 DBMET02379 0.877 0.002 DBMET02380 | ||
| 0.914 | 0.003 | 0.914 | CDK/cyclin complex inhibitor | 0.844 0.003 DBMET02363 0.825 0.004 DBMET02366 0.844 0.003 DBMET02364 0.87 0.003 DBMET02365 0.84 0.003 DBMET02372 0.86 0.003 DBMET02371 0.902 0.003 DBMET02373 0.818 0.004 DBMET02374 0.828 0.003 DBMET02375 0.85 0.003 DBMET02376 0.783 0.004 DBMET02377 0.856 0.003 DBMET02378 0.856 0.003 DBMET02379 0.892 0.003 DBMET02380 | ||
| 0.907 | 0.001 | 0.907 | Cyclin A inhibitor | 0.723 0.002 DBMET02363 0.622 0.003 DBMET02366 0.723 0.002 DBMET02364 0.839 0.002 DBMET02365 0.492 0.003 DBMET02372 0.624 0.003 DBMET02371 0.793 0.002 DBMET02373 0.59 0.003 DBMET02374 0.693 0.002 DBMET02375 0.582 0.003 DBMET02376 0.429 0.004 DBMET02377 0.748 0.002 DBMET02378 0.782 0.002 DBMET02379 0.892 0.002 DBMET02380 | ||
| 0.907 | 0.003 | 0.907 | Cyclin-dependent kinase inhibitor | 0.846 0.004 DBMET02363 0.825 0.004 DBMET02366 0.846 0.004 DBMET02364 0.875 0.003 DBMET02365 0.803 0.004 DBMET02372 0.855 0.004 DBMET02371 0.886 0.003 DBMET02373 0.84 0.004 DBMET02374 0.84 0.004 DBMET02375 0.844 0.004 DBMET02376 0.802 0.004 DBMET02377 0.852 0.004 DBMET02378 0.849 0.004 DBMET02379 0.876 0.003 DBMET02380 | ||
| 0.888 | 0.002 | 0.888 | CDK4/cyclin D1 inhibitor | 0.759 0.002 DBMET02363 0.711 0.003 DBMET02366 0.759 0.002 DBMET02364 0.841 0.002 DBMET02365 0.639 0.003 DBMET02372 0.709 0.003 DBMET02371 0.858 0.002 DBMET02373 0.767 0.002 DBMET02374 0.727 0.003 DBMET02375 0.759 0.002 DBMET02376 0.652 0.003 DBMET02377 0.79 0.002 DBMET02378 0.786 0.002 DBMET02379 0.824 0.002 DBMET02380 | ||
| 0.87 | 0.001 | 0.87 | Cyclin D3 inhibitor | 0.782 0.001 DBMET02363 0.766 0.001 DBMET02366 0.782 0.001 DBMET02364 0.77 0.001 DBMET02365 0.763 0.001 DBMET02372 0.753 0.001 DBMET02371 0.849 0.001 DBMET02373 0.728 0.001 DBMET02374 0.801 0.001 DBMET02375 0.803 0.001 DBMET02376 0.709 0.001 DBMET02377 0.842 0.001 DBMET02378 0.796 0.001 DBMET02379 0.85 0.001 DBMET02380 | ||
| 0.868 | 0.001 | 0.868 | CDK6/cyclin D3 inhibitor | 0.655 0.002 DBMET02363 0.6 0.002 DBMET02366 0.655 0.002 DBMET02364 0.602 0.002 DBMET02365 0.506 0.002 DBMET02372 0.558 0.002 DBMET02371 0.806 0.001 DBMET02373 0.519 0.002 DBMET02374 0.66 0.002 DBMET02375 0.672 0.002 DBMET02376 0.521 0.002 DBMET02377 0.573 0.002 DBMET02378 0.677 0.002 DBMET02379 0.762 0.001 DBMET02380 | ||
| 0.867 | 0.002 | 0.867 | CDK4/cyclin D inhibitor | 0.779 0.002 DBMET02363 0.76 0.002 DBMET02366 0.779 0.002 DBMET02364 0.82 0.002 DBMET02365 0.767 0.002 DBMET02372 0.769 0.002 DBMET02371 0.845 0.002 DBMET02373 0.777 0.002 DBMET02374 0.772 0.002 DBMET02375 0.789 0.002 DBMET02376 0.715 0.002 DBMET02377 0.794 0.002 DBMET02378 0.8 0.002 DBMET02379 0.828 0.002 DBMET02380 | ||
| 0.796 | 0 | 0.796 | Cyclin-dependent kinase 6 inhibitor | 0.665 0 DBMET02363 0.417 0.001 DBMET02366 0.665 0 DBMET02364 0.509 0.001 DBMET02365 0.27 0.002 DBMET02372 0.319 0.001 DBMET02371 0.67 0 DBMET02373 0.328 0.001 DBMET02374 0.39 0.001 DBMET02375 0.406 0.001 DBMET02376 0.33 0.001 DBMET02377 0.397 0.001 DBMET02378 0.542 0.001 DBMET02379 0.607 0 DBMET02380 | ||
| 0.751 | 0.004 | 0.751 | Cyclin-dependent kinase 2 inhibitor | 0.584 0.005 DBMET02363 0.556 0.005 DBMET02366 0.584 0.005 DBMET02364 0.546 0.005 DBMET02365 0.651 0.004 DBMET02372 0.675 0.004 DBMET02371 0.709 0.004 DBMET02373 0.44 0.006 DBMET02374 0.534 0.005 DBMET02375 0.601 0.005 DBMET02376 0.47 0.005 DBMET02377 0.716 0.004 DBMET02378 0.609 0.005 DBMET02379 0.697 0.004 DBMET02380 | ||
| 0.667 | 0.004 | 0.716 | Cyclin-dependent kinase 1 inhibitor | 0.523 0.005 DBMET02363 0.495 0.005 DBMET02366 0.523 0.005 DBMET02364 0.497 0.005 DBMET02365 0.397 0.006 DBMET02372 0.565 0.004 DBMET02371 0.587 0.004 DBMET02373 0.404 0.006 DBMET02374 0.46 0.005 DBMET02375 0.533 0.005 DBMET02376 0.436 0.005 DBMET02377 0.716 0.004 DBMET02378 0.512 0.005 DBMET02379 0.591 0.004 DBMET02380 | DBMET02378 | |
| 0.586 | 0.003 | 0.753 | Cyclin B3 inhibitor | 0.429 0.003 DBMET02363 0.506 0.003 DBMET02366 0.429 0.003 DBMET02364 0.492 0.003 DBMET02365 0.751 0.002 DBMET02372 0.446 0.003 DBMET02371 0.519 0.003 DBMET02373 0.422 0.003 DBMET02374 0.422 0.003 DBMET02375 0.425 0.003 DBMET02376 0.384 0.003 DBMET02377 0.753 0.002 DBMET02378 0.456 0.003 DBMET02379 0.485 0.003 DBMET02380 | DBMET02378 | |
| 0.566 | 0.003 | 0.735 | Cyclin B1 inhibitor | 0.397 0.003 DBMET02363 0.441 0.003 DBMET02366 0.397 0.003 DBMET02364 0.44 0.003 DBMET02365 0.643 0.003 DBMET02372 0.381 0.003 DBMET02371 0.502 0.003 DBMET02373 0.356 0.004 DBMET02374 0.376 0.003 DBMET02375 0.387 0.003 DBMET02376 0.305 0.004 DBMET02377 0.735 0.002 DBMET02378 0.442 0.003 DBMET02379 0.47 0.003 DBMET02380 | DBMET02378 | |
| 0.545 | 0.001 | 0.545 | CDK4/cyclin D3 inhibitor | 0.256 0.001 DBMET02363 0.21 0.002 DBMET02366 0.256 0.001 DBMET02364 0.158 0.002 DBMET02365 0.12 0.002 DBMET02372 0.261 0.001 DBMET02371 0.537 0.001 DBMET02373 0.09 0.003 DBMET02374 0.239 0.001 DBMET02375 0.281 0.001 DBMET02376 0.118 0.003 DBMET02377 0.175 0.002 DBMET02378 0.26 0.001 DBMET02379 0.482 0.001 DBMET02380 | ||
| 0.538 | 0.004 | 0.539 | CDK2/cyclin A inhibitor | 0.39 0.005 DBMET02363 0.384 0.005 DBMET02366 0.39 0.005 DBMET02364 0.539 0.004 DBMET02365 0.478 0.004 DBMET02372 0.448 0.005 DBMET02371 0.479 0.004 DBMET02373 0.461 0.005 DBMET02374 0.381 0.005 DBMET02375 0.402 0.005 DBMET02376 0.34 0.005 DBMET02377 0.506 0.004 DBMET02378 0.408 0.005 DBMET02379 0.503 0.004 DBMET02380 | DBMET02365 | |
| 0.474 | 0.003 | 0.641 | Cyclin B inhibitor | 0.321 0.004 DBMET02363 0.36 0.004 DBMET02366 0.321 0.004 DBMET02364 0.365 0.004 DBMET02365 0.551 0.003 DBMET02372 0.306 0.004 DBMET02371 0.408 0.003 DBMET02373 0.294 0.004 DBMET02374 0.3 0.004 DBMET02375 0.309 0.004 DBMET02376 0.249 0.004 DBMET02377 0.641 0.003 DBMET02378 0.358 0.004 DBMET02379 0.378 0.003 DBMET02380 | DBMET02378 | |
| 0.426 | 0.004 | 0.426 | CDK1/cyclin B1 inhibitor | 0.309 0.004 DBMET02363 0.283 0.005 DBMET02366 0.309 0.004 DBMET02364 0.282 0.005 DBMET02365 0.216 0.007 DBMET02372 0.306 0.004 DBMET02371 0.352 0.004 DBMET02373 0.242 0.005 DBMET02374 0.294 0.004 DBMET02375 0.304 0.004 DBMET02376 0.251 0.005 DBMET02377 0.311 0.004 DBMET02378 0.315 0.004 DBMET02379 0.389 0.004 DBMET02380 | ||
| 0.413 | 0.005 | 0.413 | Cyclin-dependent kinase 9 inhibitor | 0.329 0.008 DBMET02363 0.227 0.017 DBMET02366 0.329 0.008 DBMET02364 0.169 0.029 DBMET02365 0.177 0.027 DBMET02372 0.296 0.01 DBMET02371 0.303 0.009 DBMET02373 0.086 0.082 DBMET02374 0.339 0.007 DBMET02375 0.198 0.023 DBMET02376 0.111 0.052 DBMET02377 0.292 0.01 DBMET02378 0.23 0.017 DBMET02379 0.387 0.005 DBMET02380 | ||
| 0.466 | 0.103 | 0.528 | Antiinflammatory | 0.528 0.076 DBMET02363 0.501 0.087 DBMET02366 0.528 0.076 DBMET02364 0.372 0.157 DBMET02372 0.39 0.145 DBMET02371 0.481 0.096 DBMET02373 0.357 0.167 DBMET02375 0.419 0.128 DBMET02376 0.473 0.1 DBMET02377 0.504 0.086 DBMET02378 0.338 0.182 DBMET02379 0.482 0.096 DBMET02380 | DBMET02364 | |
| 0.379 | 0.02 | 0.434 | Death-associated protein kinase 3 inhibitor | 0.314 0.034 DBMET02363 0.331 0.03 DBMET02366 0.314 0.034 DBMET02364 0.258 0.05 DBMET02365 0.379 0.02 DBMET02372 0.434 0.012 DBMET02371 0.396 0.018 DBMET02373 0.208 0.071 DBMET02374 0.263 0.048 DBMET02375 0.284 0.042 DBMET02376 0.278 0.044 DBMET02377 0.297 0.038 DBMET02378 0.292 0.04 DBMET02379 0.348 0.026 DBMET02380 | DBMET02371 | |
| 0.355 | 0.003 | 0.617 | Cyclin B2 inhibitor | 0.222 0.004 DBMET02363 0.287 0.004 DBMET02366 0.222 0.004 DBMET02364 0.261 0.004 DBMET02365 0.617 0.003 DBMET02372 0.248 0.004 DBMET02371 0.293 0.004 DBMET02373 0.208 0.004 DBMET02374 0.205 0.004 DBMET02375 0.212 0.004 DBMET02376 0.202 0.004 DBMET02377 0.538 0.003 DBMET02378 0.239 0.004 DBMET02379 0.267 0.004 DBMET02380 | DBMET02372 | |
| 0.343 | 0.006 | 0.371 | Breast cancer-resistant protein inhibitor | 0.256 0.009 DBMET02363 0.248 0.009 DBMET02366 0.256 0.009 DBMET02364 0.221 0.012 DBMET02365 0.371 0.005 DBMET02372 0.219 0.012 DBMET02371 0.274 0.008 DBMET02373 0.19 0.015 DBMET02374 0.229 0.011 DBMET02375 0.259 0.009 DBMET02376 0.216 0.012 DBMET02377 0.132 0.032 DBMET02378 0.249 0.009 DBMET02379 0.339 0.006 DBMET02380 | DBMET02372 | |
| 0.337 | 0.005 | 0.337 | CDK1/cyclin B inhibitor | 0.262 0.007 DBMET02363 0.248 0.007 DBMET02366 0.262 0.007 DBMET02364 0.184 0.01 DBMET02365 0.276 0.006 DBMET02372 0.295 0.006 DBMET02371 0.332 0.005 DBMET02373 0.139 0.015 DBMET02374 0.189 0.01 DBMET02375 0.244 0.007 DBMET02376 0.174 0.011 DBMET02377 0.257 0.007 DBMET02378 0.219 0.009 DBMET02379 0.294 0.006 DBMET02380 | ||
| 0.324 | 0.009 | 0.324 | Activin receptor-like kinase 2 inhibitor | 0.217 0.03 DBMET02363 0.204 0.035 DBMET02366 0.217 0.03 DBMET02364 0.133 0.082 DBMET02365 0.255 0.02 DBMET02373 0.121 0.095 DBMET02375 0.148 0.068 DBMET02376 0.227 0.027 DBMET02378 0.22 0.029 DBMET02379 0.24 0.023 DBMET02380 | ||
| 0.345 | 0.035 | 0.37 | Tyrosine kinase inhibitor | 0.224 0.061 DBMET02363 0.311 0.041 DBMET02366 0.224 0.061 DBMET02364 0.131 0.101 DBMET02365 0.118 0.11 DBMET02372 0.286 0.046 DBMET02371 0.284 0.046 DBMET02373 0.12 0.108 DBMET02374 0.205 0.067 DBMET02375 0.179 0.076 DBMET02376 0.16 0.084 DBMET02377 0.226 0.06 DBMET02378 0.205 0.067 DBMET02379 0.37 0.032 DBMET02380 | DBMET02380 | |
| 0.298 | 0.025 | 0.396 | Protein kinase C nu inhibitor | 0.245 0.035 DBMET02363 0.218 0.041 DBMET02366 0.245 0.035 DBMET02364 0.295 0.025 DBMET02365 0.29 0.026 DBMET02372 0.396 0.01 DBMET02371 0.292 0.026 DBMET02373 0.225 0.039 DBMET02374 0.14 0.076 DBMET02375 0.207 0.045 DBMET02376 0.21 0.044 DBMET02377 0.182 0.054 DBMET02378 0.192 0.05 DBMET02379 0.235 0.037 DBMET02380 | DBMET02371 | |
| 0.291 | 0.034 | 0.338 | CDC-like kinase 2 inhibitor | 0.212 0.06 DBMET02363 0.206 0.063 DBMET02366 0.212 0.06 DBMET02364 0.161 0.087 DBMET02365 0.247 0.047 DBMET02372 0.338 0.023 DBMET02371 0.254 0.044 DBMET02373 0.126 0.113 DBMET02374 0.188 0.073 DBMET02375 0.213 0.06 DBMET02376 0.201 0.066 DBMET02377 0.206 0.063 DBMET02378 0.235 0.051 DBMET02379 0.261 0.042 DBMET02380 | DBMET02371 | |
| 0.345 | 0.096 | 0.394 | MAP kinase kinase 6 inhibitor | 0.312 0.125 DBMET02363 0.306 0.13 DBMET02366 0.312 0.125 DBMET02364 0.277 0.159 DBMET02365 0.394 0.062 DBMET02372 0.342 0.099 DBMET02371 0.342 0.099 DBMET02373 0.272 0.164 DBMET02375 0.267 0.169 DBMET02376 0.287 0.149 DBMET02377 0.351 0.091 DBMET02378 0.257 0.181 DBMET02379 0.315 0.122 DBMET02380 | DBMET02372 | |
| 0.263 | 0.02 | 0.276 | Polo-like kinase-3 inhibitor | 0.206 0.042 DBMET02363 0.22 0.035 DBMET02366 0.206 0.042 DBMET02364 0.179 0.058 DBMET02365 0.24 0.028 DBMET02372 0.239 0.028 DBMET02371 0.276 0.017 DBMET02373 0.143 0.092 DBMET02374 0.221 0.035 DBMET02375 0.212 0.039 DBMET02376 0.233 0.03 DBMET02377 0.245 0.026 DBMET02378 0.243 0.027 DBMET02379 0.25 0.024 DBMET02380 | DBMET02373 | |
| 0.262 | 0.023 | 0.27 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.199 0.043 DBMET02363 0.203 0.041 DBMET02366 0.199 0.043 DBMET02364 0.168 0.06 DBMET02365 0.198 0.043 DBMET02372 0.27 0.021 DBMET02371 0.227 0.031 DBMET02373 0.137 0.086 DBMET02374 0.183 0.051 DBMET02375 0.17 0.059 DBMET02376 0.184 0.05 DBMET02377 0.182 0.052 DBMET02378 0.203 0.041 DBMET02379 0.239 0.028 DBMET02380 | DBMET02371 | |
| 0.241 | 0.004 | 0.258 | Polo-like kinase-1 inhibitor | 0.161 0.013 DBMET02363 0.198 0.007 DBMET02366 0.161 0.013 DBMET02364 0.117 0.032 DBMET02365 0.175 0.01 DBMET02372 0.236 0.004 DBMET02371 0.258 0.004 DBMET02373 0.142 0.02 DBMET02375 0.15 0.017 DBMET02376 0.207 0.005 DBMET02377 0.217 0.005 DBMET02378 0.206 0.006 DBMET02379 0.241 0.004 DBMET02380 | DBMET02373 | |
| 0.275 | 0.04 | 0.275 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.244 0.074 DBMET02363 0.255 0.06 DBMET02366 0.244 0.074 DBMET02364 0.234 0.089 DBMET02365 0.253 0.062 DBMET02372 0.228 0.099 DBMET02371 0.262 0.051 DBMET02373 0.225 0.106 DBMET02374 0.223 0.108 DBMET02375 0.233 0.091 DBMET02376 0.197 0.174 DBMET02377 0.263 0.05 DBMET02378 0.224 0.107 DBMET02379 0.25 0.065 DBMET02380 | ||
| 0.233 | 0.005 | 0.28 | Cyclin E1 inhibitor | 0.176 0.006 DBMET02363 0.17 0.007 DBMET02366 0.176 0.006 DBMET02364 0.169 0.007 DBMET02365 0.223 0.005 DBMET02372 0.215 0.005 DBMET02371 0.197 0.005 DBMET02373 0.142 0.009 DBMET02374 0.156 0.008 DBMET02375 0.158 0.008 DBMET02376 0.164 0.007 DBMET02377 0.28 0.004 DBMET02378 0.161 0.007 DBMET02379 0.193 0.005 DBMET02380 | DBMET02378 | |
| 0.225 | 0.003 | 0.225 | Cyclin D1 inhibitor | 0.182 0.003 DBMET02363 0.159 0.004 DBMET02366 0.182 0.003 DBMET02364 0.104 0.007 DBMET02365 0.171 0.003 DBMET02372 0.156 0.004 DBMET02371 0.165 0.004 DBMET02373 0.065 0.035 DBMET02374 0.091 0.011 DBMET02375 0.092 0.01 DBMET02376 0.115 0.005 DBMET02377 0.169 0.003 DBMET02378 0.096 0.009 DBMET02379 0.183 0.003 DBMET02380 | ||
| 0.224 | 0.005 | 0.261 | Cyclin E inhibitor | 0.177 0.007 DBMET02363 0.173 0.008 DBMET02366 0.177 0.007 DBMET02364 0.172 0.008 DBMET02365 0.212 0.005 DBMET02372 0.221 0.005 DBMET02371 0.194 0.006 DBMET02373 0.145 0.011 DBMET02374 0.156 0.009 DBMET02375 0.167 0.008 DBMET02376 0.175 0.007 DBMET02377 0.261 0.004 DBMET02378 0.162 0.009 DBMET02379 0.19 0.006 DBMET02380 | DBMET02378 | |
| 0.253 | 0.034 | 0.253 | Growth factor antagonist | 0.159 0.064 DBMET02363 0.206 0.044 DBMET02366 0.159 0.064 DBMET02364 0.201 0.046 DBMET02365 0.174 0.056 DBMET02371 0.216 0.042 DBMET02373 0.168 0.059 DBMET02374 0.131 0.082 DBMET02375 0.158 0.064 DBMET02376 0.131 0.082 DBMET02377 0.215 0.042 DBMET02378 0.182 0.052 DBMET02379 0.252 0.034 DBMET02380 | ||
| 0.242 | 0.028 | 0.242 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.162 0.048 DBMET02363 0.126 0.064 DBMET02366 0.162 0.048 DBMET02364 0.16 0.049 DBMET02371 0.199 0.037 DBMET02373 0.109 0.074 DBMET02376 0.153 0.052 DBMET02378 0.121 0.068 DBMET02379 0.216 0.033 DBMET02380 | ||
| 0.218 | 0.006 | 0.218 | CDK9/cyclin T1 inhibitor | 0.136 0.012 DBMET02363 0.127 0.013 DBMET02366 0.136 0.012 DBMET02364 0.111 0.016 DBMET02365 0.08 0.026 DBMET02372 0.178 0.008 DBMET02371 0.189 0.007 DBMET02373 0.089 0.023 DBMET02374 0.128 0.013 DBMET02375 0.138 0.011 DBMET02376 0.119 0.014 DBMET02377 0.128 0.013 DBMET02378 0.142 0.011 DBMET02379 0.198 0.007 DBMET02380 | ||
| 0.267 | 0.058 | 0.279 | Potassium channel blocker | 0.23 0.076 DBMET02363 0.23 0.076 DBMET02364 0.151 0.135 DBMET02371 0.202 0.091 DBMET02373 0.279 0.054 DBMET02380 | DBMET02380 | |
| 0.227 | 0.027 | 0.257 | Ribosomal protein S6 kinase inhibitor | 0.168 0.053 DBMET02363 0.19 0.041 DBMET02366 0.168 0.053 DBMET02364 0.127 0.083 DBMET02365 0.181 0.046 DBMET02372 0.238 0.024 DBMET02371 0.257 0.019 DBMET02373 0.154 0.061 DBMET02375 0.152 0.063 DBMET02376 0.137 0.075 DBMET02377 0.169 0.053 DBMET02378 0.191 0.04 DBMET02379 0.19 0.041 DBMET02380 | DBMET02373 | |
| 0.24 | 0.043 | 0.24 | Focal adhesion kinase 2 inhibitor | 0.152 0.127 DBMET02371 0.195 0.074 DBMET02373 0.229 0.049 DBMET02378 0.202 0.068 DBMET02380 | ||
| 0.253 | 0.057 | 0.263 | MAP-kinase-activated kinase 5 inhibitor | 0.22 0.082 DBMET02363 0.216 0.086 DBMET02366 0.22 0.082 DBMET02364 0.243 0.064 DBMET02365 0.163 0.16 DBMET02371 0.263 0.051 DBMET02373 0.189 0.118 DBMET02374 0.227 0.076 DBMET02376 0.24 0.066 DBMET02378 0.198 0.105 DBMET02379 0.188 0.119 DBMET02380 | DBMET02373 | |
| 0.212 | 0.02 | 0.212 | MAP kinase 9 inhibitor | 0.188 0.025 DBMET02363 0.12 0.049 DBMET02366 0.188 0.025 DBMET02364 0.099 0.063 DBMET02365 0.148 0.038 DBMET02372 0.164 0.032 DBMET02371 0.183 0.026 DBMET02373 0.166 0.032 DBMET02375 0.15 0.038 DBMET02376 0.109 0.057 DBMET02377 0.156 0.035 DBMET02378 0.107 0.058 DBMET02379 0.177 0.028 DBMET02380 | ||
| 0.239 | 0.05 | 0.268 | CDC-like kinase 4 inhibitor | 0.161 0.093 DBMET02363 0.164 0.09 DBMET02366 0.161 0.093 DBMET02364 0.207 0.064 DBMET02372 0.268 0.04 DBMET02371 0.243 0.048 DBMET02373 0.178 0.08 DBMET02375 0.166 0.088 DBMET02376 0.149 0.102 DBMET02377 0.162 0.091 DBMET02378 0.185 0.076 DBMET02379 0.208 0.064 DBMET02380 | DBMET02371 | |
| 0.192 | 0.008 | 0.211 | CDK2/cyclin E inhibitor | 0.14 0.014 DBMET02363 0.162 0.011 DBMET02366 0.14 0.014 DBMET02364 0.117 0.018 DBMET02365 0.211 0.007 DBMET02372 0.199 0.008 DBMET02371 0.159 0.012 DBMET02373 0.092 0.026 DBMET02374 0.119 0.017 DBMET02375 0.149 0.013 DBMET02376 0.138 0.015 DBMET02377 0.147 0.013 DBMET02378 0.138 0.015 DBMET02379 0.176 0.01 DBMET02380 | DBMET02372 | |
| 0.207 | 0.038 | 0.239 | Lck kinase inhibitor | 0.166 0.056 DBMET02363 0.18 0.049 DBMET02366 0.166 0.056 DBMET02364 0.124 0.082 DBMET02365 0.239 0.027 DBMET02371 0.178 0.051 DBMET02373 0.118 0.086 DBMET02375 0.145 0.069 DBMET02376 0.171 0.054 DBMET02377 0.197 0.042 DBMET02378 0.166 0.056 DBMET02379 0.19 0.045 DBMET02380 | DBMET02371 | |
| 0.172 | 0.014 | 0.172 | CDK2/cyclin E2 inhibitor | 0.119 0.023 DBMET02363 0.099 0.028 DBMET02366 0.119 0.023 DBMET02364 0.081 0.038 DBMET02365 0.132 0.02 DBMET02372 0.161 0.015 DBMET02371 0.129 0.021 DBMET02373 0.064 0.056 DBMET02374 0.097 0.029 DBMET02375 0.087 0.034 DBMET02376 0.101 0.027 DBMET02377 0.097 0.029 DBMET02378 0.093 0.031 DBMET02379 0.13 0.02 DBMET02380 | ||
| 0.173 | 0.015 | 0.173 | ALK inhibitor | 0.135 0.023 DBMET02363 0.149 0.02 DBMET02366 0.135 0.023 DBMET02364 0.095 0.044 DBMET02365 0.11 0.035 DBMET02371 0.156 0.018 DBMET02373 0.081 0.058 DBMET02375 0.1 0.041 DBMET02376 0.126 0.027 DBMET02378 0.118 0.031 DBMET02379 0.17 0.016 DBMET02380 | ||
| 0.222 | 0.067 | 0.263 | Clk dual-specificity kinase inhibitor | 0.143 0.121 DBMET02363 0.156 0.108 DBMET02366 0.143 0.121 DBMET02364 0.257 0.052 DBMET02372 0.263 0.05 DBMET02371 0.22 0.068 DBMET02373 0.156 0.108 DBMET02375 0.148 0.116 DBMET02376 0.137 0.126 DBMET02377 0.143 0.12 DBMET02378 0.16 0.106 DBMET02379 0.185 0.088 DBMET02380 | DBMET02371 | |
| 0.154 | 0.003 | 0.154 | Cyclin E2 inhibitor | 0.083 0.005 DBMET02363 0.078 0.005 DBMET02366 0.083 0.005 DBMET02364 0.085 0.005 DBMET02365 0.087 0.005 DBMET02372 0.133 0.004 DBMET02371 0.084 0.005 DBMET02373 0.034 0.015 DBMET02374 0.051 0.009 DBMET02376 0.041 0.012 DBMET02377 0.118 0.004 DBMET02378 0.05 0.009 DBMET02379 0.053 0.008 DBMET02380 | ||
| 0.174 | 0.024 | 0.184 | Fibroblast growth factor 1 antagonist | 0.118 0.045 DBMET02363 0.184 0.02 DBMET02366 0.118 0.045 DBMET02364 0.107 0.052 DBMET02372 0.141 0.034 DBMET02371 0.164 0.027 DBMET02373 0.082 0.072 DBMET02375 0.117 0.045 DBMET02376 0.084 0.071 DBMET02377 0.144 0.033 DBMET02378 0.11 0.049 DBMET02379 0.153 0.03 DBMET02380 | DBMET02366 | |
| 0.168 | 0.024 | 0.19 | MAP kinase 8 inhibitor | 0.156 0.027 DBMET02363 0.121 0.042 DBMET02366 0.156 0.027 DBMET02364 0.106 0.054 DBMET02365 0.127 0.039 DBMET02372 0.168 0.024 DBMET02371 0.139 0.034 DBMET02373 0.086 0.08 DBMET02374 0.19 0.018 DBMET02375 0.119 0.044 DBMET02376 0.114 0.048 DBMET02377 0.132 0.037 DBMET02378 0.099 0.062 DBMET02379 0.172 0.022 DBMET02380 | DBMET02375 | |
| 0.158 | 0.022 | 0.183 | Protein kinase C mu inhibitor | 0.141 0.03 DBMET02363 0.135 0.033 DBMET02366 0.141 0.03 DBMET02364 0.172 0.018 DBMET02365 0.149 0.026 DBMET02371 0.183 0.015 DBMET02373 0.119 0.042 DBMET02374 0.087 0.072 DBMET02376 0.145 0.028 DBMET02378 0.143 0.029 DBMET02379 0.085 0.073 DBMET02380 | DBMET02373 | |
| 0.193 | 0.057 | 0.214 | Src kinase inhibitor | 0.146 0.086 DBMET02363 0.173 0.069 DBMET02366 0.146 0.086 DBMET02364 0.214 0.048 DBMET02371 0.179 0.065 DBMET02373 0.153 0.081 DBMET02374 0.126 0.102 DBMET02376 0.166 0.073 DBMET02377 0.182 0.064 DBMET02378 0.155 0.08 DBMET02379 0.179 0.066 DBMET02380 | DBMET02371 | |
| 0.204 | 0.069 | 0.208 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.183 0.091 DBMET02363 0.187 0.086 DBMET02366 0.183 0.091 DBMET02364 0.208 0.066 DBMET02371 0.184 0.089 DBMET02373 0.161 0.118 DBMET02376 0.185 0.089 DBMET02377 0.181 0.093 DBMET02378 0.177 0.098 DBMET02379 0.19 0.083 DBMET02380 | DBMET02371 | |
| 0.182 | 0.047 | 0.182 | RET inhibitor | 0.134 0.07 DBMET02363 0.15 0.062 DBMET02366 0.134 0.07 DBMET02364 0.158 0.057 DBMET02371 0.162 0.055 DBMET02373 0.106 0.091 DBMET02378 0.105 0.092 DBMET02379 0.172 0.051 DBMET02380 | ||
| 0.145 | 0.013 | 0.259 | mTOR complex 1 inhibitor | 0.135 0.017 DBMET02363 0.134 0.017 DBMET02366 0.135 0.017 DBMET02364 0.129 0.02 DBMET02365 0.259 0.004 DBMET02372 0.139 0.015 DBMET02371 0.161 0.009 DBMET02373 0.121 0.028 DBMET02374 0.128 0.021 DBMET02375 0.131 0.019 DBMET02376 0.128 0.021 DBMET02377 0.143 0.013 DBMET02378 0.131 0.019 DBMET02379 0.151 0.011 DBMET02380 | DBMET02372 | |
| 0.24 | 0.116 | 0.288 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.244 0.112 DBMET02363 0.206 0.15 DBMET02366 0.244 0.112 DBMET02364 0.288 0.073 DBMET02365 0.242 0.114 DBMET02371 0.208 0.148 DBMET02373 0.234 0.121 DBMET02374 0.217 0.139 DBMET02378 0.219 0.137 DBMET02380 | DBMET02365 | |
| 0.145 | 0.022 | 0.177 | Leucine-rich repeat kinase 2 inhibitor | 0.093 0.047 DBMET02363 0.093 0.047 DBMET02364 0.101 0.042 DBMET02371 0.177 0.013 DBMET02373 0.07 0.069 DBMET02376 0.146 0.021 DBMET02380 | DBMET02373 | |
| 0.197 | 0.073 | 0.278 | I kappa B kinase epsilon inhibitor | 0.18 0.089 DBMET02366 0.278 0.024 DBMET02378 0.224 0.053 DBMET02380 | DBMET02378 | |
| 0.127 | 0.005 | 0.196 | Fibroblast growth factor 4 antagonist | 0.1 0.009 DBMET02363 0.109 0.007 DBMET02366 0.1 0.009 DBMET02364 0.196 0.004 DBMET02365 0.1 0.009 DBMET02372 0.114 0.007 DBMET02371 0.114 0.007 DBMET02373 0.17 0.005 DBMET02374 0.097 0.01 DBMET02375 0.098 0.009 DBMET02376 0.09 0.013 DBMET02377 0.121 0.006 DBMET02378 0.14 0.005 DBMET02379 0.118 0.006 DBMET02380 | DBMET02365 | |
| 0.127 | 0.007 | 0.14 | Polo-like kinase-2 inhibitor | 0.107 0.019 DBMET02363 0.117 0.012 DBMET02366 0.107 0.019 DBMET02364 0.108 0.019 DBMET02365 0.114 0.014 DBMET02372 0.107 0.02 DBMET02371 0.14 0.005 DBMET02373 0.093 0.032 DBMET02374 0.105 0.021 DBMET02375 0.108 0.019 DBMET02376 0.108 0.018 DBMET02377 0.115 0.013 DBMET02378 0.122 0.009 DBMET02379 0.125 0.008 DBMET02380 | DBMET02373 | |
| 0.166 | 0.049 | 0.218 | Cyclin-dependent kinase 7 inhibitor | 0.143 0.065 DBMET02363 0.127 0.079 DBMET02366 0.143 0.065 DBMET02364 0.218 0.028 DBMET02371 0.135 0.072 DBMET02373 0.101 0.099 DBMET02376 0.108 0.093 DBMET02377 0.145 0.063 DBMET02378 0.157 0.055 DBMET02380 | DBMET02371 | |
| 0.187 | 0.074 | 0.236 | TRKC antagonist | 0.177 0.081 DBMET02363 0.151 0.1 DBMET02366 0.177 0.081 DBMET02364 0.174 0.083 DBMET02372 0.236 0.053 DBMET02371 0.165 0.09 DBMET02373 0.15 0.101 DBMET02375 0.155 0.097 DBMET02377 0.195 0.07 DBMET02378 0.172 0.084 DBMET02380 | DBMET02371 | |
| 0.192 | 0.08 | 0.343 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.144 0.117 DBMET02363 0.144 0.118 DBMET02366 0.144 0.117 DBMET02364 0.145 0.116 DBMET02365 0.134 0.132 DBMET02372 0.343 0.03 DBMET02371 0.17 0.096 DBMET02373 0.221 0.066 DBMET02378 0.145 0.116 DBMET02379 0.152 0.11 DBMET02380 | DBMET02371 | |
| 0.112 | 0.005 | 0.113 | Cyclin H inhibitor | 0.1 0.008 DBMET02363 0.089 0.013 DBMET02366 0.1 0.008 DBMET02364 0.094 0.01 DBMET02365 0.079 0.019 DBMET02371 0.104 0.007 DBMET02373 0.082 0.018 DBMET02374 0.092 0.011 DBMET02375 0.098 0.008 DBMET02376 0.075 0.024 DBMET02377 0.11 0.005 DBMET02378 0.093 0.011 DBMET02379 0.113 0.005 DBMET02380 | DBMET02380 | |
| 0.179 | 0.076 | 0.234 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.147 0.097 DBMET02363 0.125 0.121 DBMET02366 0.147 0.097 DBMET02364 0.135 0.109 DBMET02372 0.234 0.054 DBMET02371 0.159 0.088 DBMET02373 0.179 0.076 DBMET02378 0.173 0.079 DBMET02380 | DBMET02371 | |
| 0.123 | 0.021 | 0.13 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.072 0.05 DBMET02363 0.075 0.046 DBMET02366 0.072 0.05 DBMET02364 0.08 0.041 DBMET02372 0.093 0.032 DBMET02371 0.097 0.03 DBMET02373 0.067 0.056 DBMET02375 0.064 0.06 DBMET02376 0.097 0.03 DBMET02378 0.078 0.043 DBMET02379 0.13 0.019 DBMET02380 | DBMET02380 | |
| 0.128 | 0.026 | 0.163 | Platelet growth factor antagonist | 0.098 0.042 DBMET02363 0.109 0.035 DBMET02366 0.098 0.042 DBMET02364 0.163 0.016 DBMET02372 0.106 0.037 DBMET02371 0.109 0.035 DBMET02373 0.073 0.064 DBMET02375 0.078 0.059 DBMET02376 0.093 0.046 DBMET02377 0.081 0.055 DBMET02378 0.092 0.047 DBMET02379 0.106 0.037 DBMET02380 | DBMET02372 | |
| 0.141 | 0.041 | 0.141 | Platelet activating factor beta antagonist | 0.08 0.079 DBMET02363 0.094 0.067 DBMET02366 0.08 0.079 DBMET02364 0.125 0.048 DBMET02371 0.109 0.057 DBMET02373 0.083 0.076 DBMET02376 0.091 0.069 DBMET02377 0.095 0.066 DBMET02378 0.111 0.055 DBMET02380 | ||
| 0.141 | 0.046 | 0.165 | Cyclin-dependent kinase 5 inhibitor | 0.117 0.06 DBMET02363 0.12 0.058 DBMET02366 0.117 0.06 DBMET02364 0.094 0.08 DBMET02365 0.149 0.041 DBMET02372 0.165 0.033 DBMET02371 0.132 0.051 DBMET02373 0.099 0.076 DBMET02375 0.098 0.077 DBMET02376 0.114 0.063 DBMET02377 0.098 0.077 DBMET02378 0.095 0.079 DBMET02379 0.11 0.067 DBMET02380 | DBMET02371 | |
| 0.151 | 0.064 | 0.151 | Tyrosine-protein kinase receptor antagonist | 0.148 0.065 DBMET02363 0.148 0.065 DBMET02364 0.117 0.09 DBMET02371 0.147 0.066 DBMET02373 0.147 0.066 DBMET02378 0.147 0.065 DBMET02380 | ||
| 0.14 | 0.057 | 0.182 | MAP kinase kinase inhibitor | 0.138 0.058 DBMET02363 0.138 0.058 DBMET02364 0.141 0.056 DBMET02372 0.173 0.04 DBMET02371 0.115 0.078 DBMET02373 0.182 0.035 DBMET02378 0.135 0.061 DBMET02380 | DBMET02378 | |
| 0.147 | 0.067 | 0.158 | Protein-tyrosine kinase Lyn inhibitor | 0.109 0.094 DBMET02363 0.109 0.094 DBMET02364 0.158 0.062 DBMET02371 0.119 0.086 DBMET02373 0.138 0.072 DBMET02378 0.117 0.087 DBMET02379 0.143 0.069 DBMET02380 | DBMET02371 | |
| 0.108 | 0.028 | 0.12 | Fibroblast growth factor 3 antagonist | 0.12 0.023 DBMET02371 0.117 0.024 DBMET02373 0.094 0.036 DBMET02380 | DBMET02371 | |
| 0.115 | 0.036 | 0.148 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.108 0.039 DBMET02363 0.108 0.039 DBMET02364 0.148 0.023 DBMET02371 0.085 0.063 DBMET02373 0.107 0.04 DBMET02378 0.11 0.038 DBMET02380 | DBMET02371 | |
| 0.115 | 0.037 | 0.158 | Insulin growth factor antagonist | 0.084 0.061 DBMET02371 0.086 0.059 DBMET02373 0.092 0.053 DBMET02378 0.158 0.02 DBMET02380 | DBMET02380 | |
| 0.092 | 0.016 | 0.092 | MAP kinase 7 inhibitor | 0.088 0.023 DBMET02363 0.08 0.046 DBMET02366 0.088 0.023 DBMET02364 0.082 0.039 DBMET02365 0.075 0.065 DBMET02371 0.089 0.021 DBMET02373 0.074 0.07 DBMET02374 0.082 0.037 DBMET02375 0.084 0.032 DBMET02376 0.088 0.023 DBMET02378 0.081 0.04 DBMET02379 0.087 0.024 DBMET02380 | ||
| 0.109 | 0.035 | 0.153 | Insulin like growth factor 1 antagonist | 0.082 0.058 DBMET02371 0.084 0.056 DBMET02373 0.078 0.063 DBMET02378 0.153 0.019 DBMET02380 | DBMET02380 | |
| 0.102 | 0.028 | 0.102 | Focal adhesion kinase 1 inhibitor | 0.081 0.048 DBMET02363 0.1 0.03 DBMET02366 0.081 0.048 DBMET02364 0.076 0.054 DBMET02365 0.089 0.04 DBMET02371 0.091 0.038 DBMET02373 0.076 0.054 DBMET02375 0.083 0.046 DBMET02376 0.094 0.035 DBMET02378 0.08 0.049 DBMET02379 0.094 0.034 DBMET02380 | ||
| 0.124 | 0.05 | 0.132 | Granulocyte macrophage colony stimulating factor antagonist | 0.108 0.063 DBMET02371 0.112 0.059 DBMET02373 0.095 0.077 DBMET02378 0.132 0.045 DBMET02380 | DBMET02380 | |
| 0.092 | 0.021 | 0.092 | 5 Hydroxytryptamine 3A antagonist | 0.072 0.04 DBMET02378 | ||
| 0.11 | 0.04 | 0.12 | Protein kinase C zeta inhibitor | 0.105 0.045 DBMET02363 0.105 0.045 DBMET02364 0.095 0.057 DBMET02365 0.094 0.058 DBMET02372 0.087 0.07 DBMET02373 0.12 0.033 DBMET02378 0.09 0.065 DBMET02379 | DBMET02378 | |
| 0.21 | 0.141 | 0.259 | Hypoxia-inducible factor 1 alpha inhibitor | 0.247 0.104 DBMET02363 0.239 0.111 DBMET02366 0.247 0.104 DBMET02364 0.259 0.092 DBMET02372 0.182 0.175 DBMET02377 0.203 0.149 DBMET02378 | DBMET02372 | |
| 0.177 | 0.112 | 0.262 | Dyrk kinase inhibitor | 0.164 0.123 DBMET02366 0.231 0.081 DBMET02372 0.262 0.067 DBMET02371 0.147 0.139 DBMET02373 0.151 0.135 DBMET02377 0.146 0.14 DBMET02378 | DBMET02371 | |
| 0.094 | 0.031 | 0.131 | Syk tyrosine kinase inhibitor | 0.066 0.054 DBMET02363 0.063 0.056 DBMET02366 0.066 0.054 DBMET02364 0.131 0.018 DBMET02371 0.092 0.032 DBMET02373 0.112 0.023 DBMET02378 0.083 0.038 DBMET02380 | DBMET02371 | |
| 0.145 | 0.084 | 0.167 | Cyclin-dependent kinase 8 inhibitor | 0.143 0.086 DBMET02363 0.143 0.086 DBMET02364 0.162 0.068 DBMET02371 0.167 0.063 DBMET02373 | DBMET02373 | |
| 0.11 | 0.05 | 0.121 | Insulin receptor antagonist | 0.086 0.084 DBMET02372 0.121 0.041 DBMET02371 0.094 0.07 DBMET02373 0.105 0.055 DBMET02380 | DBMET02371 | |
| 0.096 | 0.038 | 0.217 | mTOR complex 2 inhibitor | 0.081 0.066 DBMET02363 0.088 0.05 DBMET02366 0.081 0.066 DBMET02364 0.078 0.075 DBMET02365 0.217 0.004 DBMET02372 0.08 0.068 DBMET02373 0.103 0.03 DBMET02378 0.099 0.034 DBMET02380 | DBMET02372 | |
| 0.097 | 0.04 | 0.097 | Acetylcholine nicotinic agonist | 0.076 0.063 DBMET02378 0.078 0.059 DBMET02380 | ||
| 0.069 | 0.013 | 0.077 | Bromodomain-containing protein 3 inhibitor | 0.057 0.024 DBMET02363 0.057 0.024 DBMET02364 0.049 0.035 DBMET02365 0.062 0.018 DBMET02373 0.054 0.027 DBMET02375 0.063 0.018 DBMET02376 0.067 0.015 DBMET02378 0.057 0.023 DBMET02379 0.077 0.01 DBMET02380 | DBMET02380 | |
| 0.084 | 0.03 | 0.086 | ZAP-70 protein tyrosine kinase inhibitor | 0.074 0.043 DBMET02363 0.077 0.039 DBMET02366 0.074 0.043 DBMET02364 0.07 0.048 DBMET02365 0.086 0.028 DBMET02371 0.083 0.031 DBMET02373 0.069 0.049 DBMET02375 0.077 0.039 DBMET02376 0.073 0.044 DBMET02377 0.081 0.034 DBMET02378 0.074 0.043 DBMET02379 0.086 0.028 DBMET02380 | DBMET02380 | |
| 0.096 | 0.044 | 0.126 | ErbB-3 antagonist | 0.085 0.055 DBMET02363 0.085 0.055 DBMET02364 0.085 0.054 DBMET02373 0.077 0.066 DBMET02375 0.082 0.058 DBMET02376 0.097 0.044 DBMET02378 0.077 0.065 DBMET02379 0.126 0.027 DBMET02380 | DBMET02380 | |
| 0.131 | 0.08 | 0.131 | Death-associated protein kinase 1 inhibitor | 0.125 0.098 DBMET02366 0.129 0.085 DBMET02372 0.126 0.093 DBMET02371 0.123 0.102 DBMET02373 0.12 0.114 DBMET02377 0.122 0.107 DBMET02378 | ||
| 0.091 | 0.041 | 0.091 | Caspase 7 inhibitor | 0.075 0.073 DBMET02372 0.09 0.042 DBMET02378 | ||
| 0.166 | 0.117 | 0.241 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.159 0.123 DBMET02366 0.235 0.074 DBMET02372 0.241 0.071 DBMET02371 0.149 0.131 DBMET02377 | DBMET02371 | |
| 0.082 | 0.033 | 0.107 | MAP kinase kinase 8 inhibitor | 0.107 0.019 DBMET02363 0.068 0.048 DBMET02366 0.107 0.019 DBMET02364 0.062 0.058 DBMET02371 0.068 0.049 DBMET02373 0.062 0.06 DBMET02375 0.07 0.046 DBMET02376 0.083 0.033 DBMET02378 0.069 0.047 DBMET02380 | DBMET02364 | |
| 0.205 | 0.158 | 0.404 | Immunomodulator | 0.293 0.087 DBMET02363 0.293 0.087 DBMET02364 0.404 0.043 DBMET02372 0.238 0.125 DBMET02371 0.206 0.157 DBMET02373 0.196 0.17 DBMET02377 0.237 0.126 DBMET02378 0.198 0.167 DBMET02380 | DBMET02372 | |
| 0.091 | 0.045 | 0.106 | ErbB-4 antagonist | 0.067 0.063 DBMET02371 0.078 0.054 DBMET02373 0.081 0.052 DBMET02378 0.106 0.037 DBMET02380 | DBMET02380 | |
| 0.092 | 0.046 | 0.107 | AXL receptor tyrosine kinase inhibitor | 0.101 0.039 DBMET02363 0.074 0.071 DBMET02366 0.101 0.039 DBMET02364 0.107 0.034 DBMET02372 0.081 0.059 DBMET02371 0.075 0.068 DBMET02373 0.085 0.054 DBMET02378 0.08 0.061 DBMET02380 | DBMET02372 | |
| 0.139 | 0.094 | 0.166 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.131 0.114 DBMET02363 0.135 0.105 DBMET02366 0.131 0.114 DBMET02364 0.148 0.076 DBMET02372 0.131 0.115 DBMET02371 0.134 0.108 DBMET02373 0.166 0.047 DBMET02378 | DBMET02378 | |
| 0.126 | 0.083 | 0.156 | Cytokine production inhibitor | 0.156 0.058 DBMET02372 0.152 0.061 DBMET02371 0.147 0.064 DBMET02377 | DBMET02372 | |
| 0.058 | 0.017 | 0.061 | CDK7/cyclin H inhibitor | 0.05 0.025 DBMET02363 0.046 0.031 DBMET02366 0.05 0.025 DBMET02364 0.045 0.032 DBMET02365 0.044 0.033 DBMET02371 0.051 0.023 DBMET02373 0.044 0.033 DBMET02375 0.048 0.027 DBMET02376 0.042 0.04 DBMET02377 0.057 0.017 DBMET02378 0.045 0.031 DBMET02379 0.061 0.015 DBMET02380 | DBMET02380 | |
| 0.084 | 0.042 | 0.117 | Janus tyrosine kinase 3 inhibitor | 0.078 0.046 DBMET02366 0.067 0.055 DBMET02373 0.062 0.061 DBMET02375 0.062 0.06 DBMET02378 0.062 0.06 DBMET02379 0.117 0.027 DBMET02380 | DBMET02380 | |
| 0.079 | 0.041 | 0.169 | MAP3K7 inhibitor | 0.083 0.036 DBMET02363 0.069 0.056 DBMET02366 0.083 0.036 DBMET02364 0.069 0.055 DBMET02365 0.07 0.054 DBMET02373 0.169 0.008 DBMET02380 | DBMET02380 | |
| 0.066 | 0.03 | 0.066 | Nicotinic neuronal receptor agonist | 0.052 0.043 DBMET02380 | ||
| 0.058 | 0.023 | 0.074 | Nicotinic receptor alpha4 subunit antagonist | 0.051 0.031 DBMET02363 0.051 0.031 DBMET02364 0.074 0.015 DBMET02365 0.046 0.041 DBMET02373 0.056 0.025 DBMET02374 0.048 0.037 DBMET02378 0.053 0.028 DBMET02379 | DBMET02365 | |
| 0.062 | 0.027 | 0.067 | mTOR inhibitor | 0.053 0.035 DBMET02363 0.053 0.035 DBMET02364 0.067 0.023 DBMET02372 0.05 0.038 DBMET02371 0.058 0.03 DBMET02373 0.053 0.034 DBMET02378 0.059 0.029 DBMET02380 | DBMET02372 | |
| 0.258 | 0.224 | 0.382 | MAP kinase 1 inhibitor | 0.382 0.117 DBMET02380 | DBMET02380 | |
| 0.114 | 0.081 | 0.114 | TRKB antagonist | 0.107 0.091 DBMET02363 0.107 0.091 DBMET02364 0.102 0.098 DBMET02371 0.112 0.083 DBMET02373 0.11 0.087 DBMET02378 0.106 0.092 DBMET02380 | ||
| 0.059 | 0.03 | 0.119 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.046 0.041 DBMET02363 0.046 0.041 DBMET02364 0.119 0.013 DBMET02372 0.06 0.03 DBMET02371 0.052 0.036 DBMET02373 0.056 0.032 DBMET02375 0.05 0.037 DBMET02378 0.062 0.028 DBMET02380 | DBMET02372 | |
| 0.07 | 0.041 | 0.109 | Fibroblast growth factor 2 antagonist | 0.066 0.044 DBMET02372 0.109 0.021 DBMET02371 0.064 0.047 DBMET02380 | DBMET02371 | |
| 0.061 | 0.034 | 0.079 | Bruton tyrosine kinase inhibitor | 0.052 0.044 DBMET02373 0.079 0.021 DBMET02380 | DBMET02380 | |
| 0.131 | 0.104 | 0.147 | MAP kinase 3 inhibitor | 0.129 0.109 DBMET02363 0.129 0.109 DBMET02364 0.125 0.121 DBMET02372 0.147 0.072 DBMET02378 0.142 0.081 DBMET02380 | DBMET02378 | |
| 0.077 | 0.05 | 0.096 | Janus tyrosine kinase 2 inhibitor | 0.065 0.061 DBMET02373 0.064 0.062 DBMET02378 0.096 0.038 DBMET02380 | DBMET02380 | |
| 0.089 | 0.064 | 0.089 | Hepatocyte growth factor antagonist | |||
| 0.07 | 0.046 | 0.07 | Toll-Like receptor 7 antagonist | |||
| 0.078 | 0.056 | 0.083 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.073 0.063 DBMET02366 0.083 0.048 DBMET02371 0.074 0.061 DBMET02379 0.074 0.061 DBMET02380 | DBMET02371 | |
| 0.085 | 0.065 | 0.101 | Bromodomain-containing protein 2 inhibitor | 0.101 0.039 DBMET02380 | DBMET02380 | |
| 0.101 | 0.084 | 0.108 | Activin receptor-like kinase 4 inhibitor | 0.108 0.069 DBMET02366 | DBMET02366 | |
| 0.103 | 0.086 | 0.106 | TRKA antagonist | 0.106 0.082 DBMET02363 0.106 0.082 DBMET02364 0.106 0.082 DBMET02373 0.103 0.085 DBMET02378 0.106 0.082 DBMET02380 | DBMET02380 | |
| 0.059 | 0.042 | 0.111 | Phosphatidylinositol kinase inhibitor | 0.111 0.018 DBMET02372 0.056 0.045 DBMET02373 0.064 0.038 DBMET02380 | DBMET02372 | |
| 0.055 | 0.039 | 0.079 | Adenine nucleotide translocase inhibitor | 0.056 0.038 DBMET02363 0.062 0.025 DBMET02366 0.056 0.038 DBMET02364 0.056 0.037 DBMET02365 0.079 0.009 DBMET02372 0.058 0.032 DBMET02371 0.052 0.048 DBMET02373 0.056 0.037 DBMET02374 0.06 0.028 DBMET02376 0.07 0.015 DBMET02377 0.052 0.051 DBMET02380 | DBMET02372 | |
| 0.059 | 0.049 | 0.06 | Tyk2 inhibitor | 0.06 0.048 DBMET02380 | DBMET02380 | |
| 0.142 | 0.138 | 0.143 | EphB2 antagonist | 0.143 0.137 DBMET02378 | DBMET02378 | |
| 0.049 | 0.047 | 0.071 | Tyrosine-protein kinase EMT inhibitor | 0.059 0.039 DBMET02371 0.071 0.03 DBMET02380 | DBMET02380 | |
| 0.027 | 0.026 | 0.027 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.036 | 0.035 | 0.128 | CDK5/p25 inhibitor | 0.128 0.005 DBMET02372 | DBMET02372 | |
| 0.137 | 0.136 | 0.161 | Antimitotic | 0.161 0.111 DBMET02371 0.159 0.113 DBMET02373 0.157 0.115 DBMET02380 | DBMET02371 | |
| 0.015 | 0.017 | 0.016 | CDK2/cyclin A3 inhibitor | 0.016 0.013 DBMET02373 | DBMET02373 | |
| 0.133 | 0.136 | 0.196 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.196 0.079 DBMET02371 0.153 0.117 DBMET02378 | DBMET02371 | |
| 0.059 | 0.062 | 0.066 | Protein kinase C alpha inhibitor | 0.066 0.051 DBMET02378 | DBMET02378 | |
| 0.088 | 0.091 | 0.108 | Platelet activating factor antagonist | 0.108 0.072 DBMET02380 | DBMET02380 | |
| 0.098 | 0.101 | 0.105 | Epidermal growth factor receptor kinase inhibitor | 0.1 0.098 DBMET02373 0.105 0.09 DBMET02380 | DBMET02380 | |
| 0.033 | 0.037 | 0.04 | Vascular adhesion protein 1 inhibitor | 0.035 0.033 DBMET02373 0.04 0.026 DBMET02380 | DBMET02380 | |
| 0.088 | 0.092 | 0.107 | Glycogen synthase kinase-3 inhibitor | 0.099 0.081 DBMET02371 0.107 0.072 DBMET02373 | DBMET02373 | |
| 0.064 | 0.068 | 0.11 | Protein kinase B gamma inhibitor | 0.11 0.028 DBMET02371 | DBMET02371 | |
| 0.059 | 0.063 | 0.067 | MAP kinase kinase 10 inhibitor | 0.06 0.059 DBMET02376 0.067 0.045 DBMET02380 | DBMET02380 | |
| 0.027 | 0.032 | 0.031 | Potassium channel (Inward rectifier) 1 blocker | 0.029 0.025 DBMET02363 0.029 0.025 DBMET02364 0.031 0.019 DBMET02372 0.03 0.023 DBMET02373 0.03 0.02 DBMET02380 | DBMET02372 | |
| 0.018 | 0.024 | 0.02 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.02 0.018 DBMET02372 | DBMET02372 | |
| 0.079 | 0.086 | 0.094 | Aurora-A kinase inhibitor | 0.094 0.071 DBMET02380 | DBMET02380 | |
| 0.145 | 0.152 | 0.238 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.201 0.09 DBMET02372 0.238 0.067 DBMET02371 0.165 0.125 DBMET02380 | DBMET02371 | |
| 0.072 | 0.08 | 0.078 | Epidermal growth factor antagonist | 0.078 0.068 DBMET02380 | DBMET02380 | |
| 0.07 | 0.079 | 0.091 | MAP-kinase-activated kinase inhibitor | 0.091 0.048 DBMET02373 | DBMET02373 | |
| 0.041 | 0.053 | 0.05 | Histamine H4 receptor antagonist | 0.05 0.031 DBMET02372 | DBMET02372 | |
| 0.136 | 0.149 | 0.184 | Platelet aggregation inhibitor | 0.169 0.107 DBMET02373 0.184 0.094 DBMET02377 | DBMET02377 | |
| 0.083 | 0.101 | 0.099 | Glycogen synthase kinase-3 beta inhibitor | 0.099 0.079 DBMET02373 | DBMET02373 | |
| 0.045 | 0.065 | 0.078 | Protein kinase C iota inhibitor | 0.078 0.027 DBMET02371 | DBMET02371 | |
| 0.04 | 0.062 | 0.072 | Histamine agonist | 0.072 0.018 DBMET02372 | DBMET02372 | |
| 0.11 | 0.133 | 0.121 | Aurora-C kinase inhibitor | 0.121 0.103 DBMET02378 | DBMET02378 | |
| 0.104 | 0.127 | 0.206 | Neurotrophic factor | 0.115 0.104 DBMET02363 0.115 0.104 DBMET02364 0.206 0.025 DBMET02372 0.122 0.092 DBMET02373 0.125 0.087 DBMET02379 0.127 0.084 DBMET02380 | DBMET02372 | |
| 0.043 | 0.068 | 0.052 | Protein kinase C theta inhibitor | 0.052 0.05 DBMET02379 | DBMET02379 | |
| 0.083 | 0.108 | 0.104 | c-Src kinase inhibitor | 0.104 0.087 DBMET02371 | DBMET02371 | |
| 0.175 | 0.201 | 0.202 | Angiogenesis inhibitor | 0.202 0.167 DBMET02371 | DBMET02371 | |
| 0.074 | 0.101 | 0.09 | Phosphodiesterase 7B inhibitor | 0.084 0.079 DBMET02372 0.09 0.07 DBMET02378 | DBMET02378 | |
| 0.073 | 0.099 | 0.083 | Ephrin antagonist | 0.083 0.081 DBMET02375 | DBMET02375 | |
| 0.056 | 0.085 | 0.075 | MAP-kinase-activated kinase 2 inhibitor | 0.075 0.051 DBMET02373 | DBMET02373 | |
| 0.074 | 0.104 | 0.098 | ABCA1 expression enhancer | 0.082 0.081 DBMET02363 0.082 0.081 DBMET02364 0.082 0.081 DBMET02372 0.089 0.067 DBMET02376 0.098 0.053 DBMET02377 | DBMET02377 | |
| 0.068 | 0.098 | 0.079 | Protein kinase C delta inhibitor | 0.079 0.078 DBMET02378 | DBMET02378 | |
| 0.074 | 0.105 | 0.091 | MAP kinase kinase 1 inhibitor | 0.09 0.069 DBMET02371 0.091 0.068 DBMET02378 | DBMET02378 | |
| 0.024 | 0.055 | 0.03 | DNA topoisomerase IV inhibitor | 0.03 0.019 DBMET02375 0.028 0.025 DBMET02378 | DBMET02375 | |
| 0.024 | 0.057 | 0.031 | Protein kinase C beta II inhibitor | 0.031 0.027 DBMET02378 | DBMET02378 | |
| 0.081 | 0.116 | 0.131 | Protein kinase C gamma inhibitor | 0.131 0.044 DBMET02378 | DBMET02378 | |
| 0.085 | 0.131 | 0.175 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.175 0.054 DBMET02371 | DBMET02371 | |
| 0.037 | 0.084 | 0.049 | Phosphodiesterase 7A inhibitor | 0.049 0.043 DBMET02372 | DBMET02372 | |
| 0.02 | 0.072 | 0.071 | Nicotinic receptor beta4 subunit antagonist | 0.071 0.009 DBMET02365 0.067 0.01 DBMET02374 | DBMET02365 | |
| 0.042 | 0.097 | 0.084 | DNA gyrase inhibitor | 0.084 0.024 DBMET02375 0.062 0.046 DBMET02378 | DBMET02375 | |
| 0.096 | 0.151 | 0.151 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.151 0.088 DBMET02371 | DBMET02371 | |
| 0.09 | 0.146 | 0.187 | Protein kinase (CK1) gamma 1 inhibitor | 0.116 0.102 DBMET02372 0.187 0.047 DBMET02371 | DBMET02371 | |
| 0.074 | 0.132 | 0.107 | Protein kinase (CK1) gamma 2 inhibitor | 0.097 0.088 DBMET02372 0.107 0.076 DBMET02371 | DBMET02371 | |
| 0.086 | 0.144 | 0.168 | Protein kinase (CK1) gamma inhibitor | 0.108 0.104 DBMET02372 0.168 0.058 DBMET02371 | DBMET02371 | |
| 0.03 | 0.092 | 0.042 | DNA gyrase subunit A inhibitor | 0.042 0.031 DBMET02378 | DBMET02378 | |
| 0.061 | 0.123 | 0.09 | MAP kinase kinase kinase inhibitor | 0.09 0.076 DBMET02380 | DBMET02380 | |
| 0.033 | 0.101 | 0.055 | Phosphodiesterase VII inhibitor | 0.055 0.054 DBMET02372 | DBMET02372 | |
| 0.025 | 0.093 | 0.043 | Adenosine uptake inhibitor | 0.043 0.009 DBMET02372 | DBMET02372 | |
| 0.025 | 0.094 | 0.049 | Phosphatidylinositol 3-kinase delta inhibitor | 0.049 0.047 DBMET02372 | DBMET02372 | |
| 0.046 | 0.116 | 0.07 | I kappa B kinase 1 inhibitor | 0.07 0.047 DBMET02371 | DBMET02371 | |
| 0.137 | 0.213 | 0.159 | MAP kinase kinase 5 inhibitor | 0.159 0.119 DBMET02372 | DBMET02372 | |
| 0.11 | 0.189 | 0.128 | CC chemokine 6 receptor antagonist | 0.12 0.118 DBMET02376 0.128 0.079 DBMET02378 | DBMET02378 | |
| 0.11 | 0.194 | 0.142 | MAP kinase kinase 4 inhibitor | 0.13 0.115 DBMET02363 0.13 0.115 DBMET02364 0.142 0.079 DBMET02372 0.127 0.123 DBMET02378 | DBMET02372 | |
| 0.041 | 0.127 | 0.114 | Protein kinase B alpha inhibitor | 0.114 0.022 DBMET02365 0.087 0.037 DBMET02374 | DBMET02365 | |
| 0.057 | 0.145 | 0.158 | Polo-like kinase-4 inhibitor | 0.158 0.031 DBMET02373 | DBMET02373 | |
| 0.092 | 0.189 | 0.149 | LIM domain kinase 1 inhibitor | 0.149 0.099 DBMET02371 | DBMET02371 | |
| 0.038 | 0.139 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.054 DBMET02373 | DBMET02373 | |
| 0.034 | 0.14 | 0.067 | Protein kinase C beta inhibitor | 0.067 0.054 DBMET02378 | DBMET02378 | |
| 0.107 | 0.214 | 0.146 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.146 0.133 DBMET02371 | DBMET02371 | |
| 0.055 | 0.17 | 0.09 | MAP kinase kinase 7 inhibitor | 0.09 0.025 DBMET02372 | DBMET02372 | |
| 0.092 | 0.209 | 0.152 | MAP kinase kinase 2 inhibitor | 0.152 0.12 DBMET02371 | DBMET02371 | |
| 0.062 | 0.182 | 0.179 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.179 0.06 DBMET02371 | DBMET02371 | |
| 0.065 | 0.199 | 0.12 | CDC-like kinase 1 inhibitor | 0.12 0.095 DBMET02372 | DBMET02372 | |
| 0.054 | 0.191 | 0.089 | Interleukin 1 beta converting enzyme inhibitor | 0.089 0.074 DBMET02377 | DBMET02377 | |
| 0.075 | 0.216 | 0.103 | Transcription factor STAT6 inhibitor | 0.103 0.099 DBMET02380 | DBMET02380 | |
| 0.032 | 0.188 | 0.253 | Protein kinase B beta inhibitor | 0.253 0.004 DBMET02365 0.228 0.004 DBMET02374 | DBMET02365 | |
| 0.074 | 0.232 | 0.125 | MAP3K9 inhibitor | 0.125 0.104 DBMET02373 | DBMET02373 | |
| 0.028 | 0.205 | 0.05 | Antiviral (Hepatitis D) | 0.05 0.036 DBMET02372 | DBMET02372 | |
| 0.113 | 0.294 | 0.31 | DNA synthesis inhibitor | 0.176 0.159 DBMET02363 0.176 0.159 DBMET02364 0.31 0.04 DBMET02372 0.224 0.089 DBMET02378 | DBMET02372 | |
| 0.098 | 0.287 | 0.151 | Death-associated protein kinase 2 inhibitor | 0.151 0.104 DBMET02371 | DBMET02371 | |
| 0.191 | 0.4 | 0.276 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.276 0.246 DBMET02378 | DBMET02378 | |
| 0.042 | 0.275 | 0.089 | Phosphodiesterase XI inhibitor | 0.089 0.044 DBMET02373 | DBMET02373 | |
| 0.042 | 0.275 | 0.089 | Phosphodiesterase 11A inhibitor | 0.089 0.044 DBMET02373 | DBMET02373 | |
| 0.006 | 0.271 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 DBMET02372 | DBMET02372 | |
| 0.105 | 0.394 | 0.486 | Histamine release inhibitor | 0.486 0.034 DBMET02372 | DBMET02372 | |
| 0.075 | 0.39 | 0.21 | Immunosuppressant | 0.21 0.186 DBMET02363 0.21 0.186 DBMET02364 | DBMET02364 | |
| 0.025 | 0.386 | 0.086 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.067 DBMET02366 | DBMET02366 | |
| 0.012 | 0.374 | 0.099 | HIV-1 reverse transcriptase inhibitor | 0.099 0.031 DBMET02375 | DBMET02375 | |
| 0.005 | 0.376 | 0.04 | Phosphodiesterase 3B inhibitor | 0.04 0.036 DBMET02373 | DBMET02373 | |
| 0.098 | 0.487 | 0.206 | Interleukin 2 agonist | 0.206 0.178 DBMET02363 0.206 0.178 DBMET02364 | DBMET02364 | |
| 0.007 | 0.432 | 0.051 | Dihydrofolate reductase inhibitor | 0.051 0.018 DBMET02372 | DBMET02372 | |
| 0.012 | 0.444 | 0.101 | Purinergic P2X2 antagonist | 0.101 0.029 DBMET02372 | DBMET02372 | |
| 0.052 | 0.52 | 0.291 | Antiobesity | 0.291 0.123 DBMET02378 | DBMET02378 | |
| 0.078 | 0.546 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.134 0.1 DBMET02372 | DBMET02372 | |
| 0.078 | 0.583 | 0.194 | Nitric-oxide synthase stimulant | 0.194 0.099 DBMET02372 | DBMET02372 | |
| 0.055 | 0.566 | 0.235 | RNA-directed DNA polymerase inhibitor | 0.235 0.06 DBMET02372 | DBMET02372 | |
| 0.04 | 0.552 | 0.139 | Folate antagonist | 0.139 0.027 DBMET02372 | DBMET02372 | |
| 0.018 | 0.541 | 0.064 | Parathyroid hormone antagonist | 0.064 0.009 DBMET02371 | DBMET02371 | |
| 0.039 | 0.565 | 0.121 | DNA repair enzyme inhibitor | 0.121 0.07 DBMET02372 | DBMET02372 | |
| 0.068 | 0.62 | 0.326 | 5 Hydroxytryptamine release inhibitor | 0.326 0.137 DBMET02372 | DBMET02372 | |
| 0.003 | 0.623 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 DBMET02365 | DBMET02365 | |
| 0.005 | 0.637 | 0.146 | NMDA 2B receptor antagonist | 0.146 0.009 DBMET02375 | DBMET02375 | |
| 0.042 | 0.709 | 0.28 | Sodium/bile acid cotransporter inhibitor | 0.28 0.098 DBMET02377 | DBMET02377 | |
| 0.023 | 0.705 | 0.149 | Neurotrophic factor enhancer | 0.149 0.139 DBMET02372 | DBMET02372 | |
| 0.014 | 0.73 | 0.13 | Antipruritic | 0.13 0.123 DBMET02372 | DBMET02372 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |